NPI: 1174041255 · ARLINGTON, VA 22202 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/08/2017
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 09/08/2017 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,999 | $42K |
| 2019 | 21,866 | $303K |
| 2020 | 14,452 | $238K |
| 2021 | 9,871 | $216K |
| 2022 | 5,849 | $312K |
| 2023 | 1,765 | $107K |
| 2024 | 1,211 | $70K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 20,324 | 1,248 | $1.24M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 22,157 | 838 | $32K |
| A4657 | Syringe, with or without needle, each | 3,328 | 953 | $8K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 137 | 53 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | 2,272 | 331 | $2K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 688 | 231 | $647.93 |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,327 | 382 | $532.70 |
| 83970 | 796 | 397 | $267.26 | |
| 90732 | 19 | 12 | $109.68 | |
| 84466 | 567 | 284 | $93.75 | |
| 85048 | 1,040 | 513 | $85.06 | |
| 82728 | 608 | 307 | $59.94 | |
| 83540 | 644 | 320 | $30.04 | |
| 85041 | 1,064 | 530 | $18.21 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 20 | 13 | $0.00 |
| 83550 | 22 | 14 | $0.00 |